Not meant to depict the results of actual
treatment with DUPIXENT.

The mechanism of dupilumab action has not been
definitively established.

  • DUPIXENT is not an immunosuppressant1
  • DUPIXENT requires no initial lab testing or ongoing lab monitoring, according to the Prescribing Information1
  • DUPIXENT is not metabolized through the liver or excreted through the kidneys1
    • No known drug-to-drug interactions
Identifying DUPIXENT Patients
Consider whether your patient with uncontrolled prurigo nodularis may
be a candidate for DUPIXENT. Take a look at our patient profiles.
Identify Patients